ATI RN · Obstetrics and Pediatrics · Fluid Maintenance Pediatrics Practice Questions

Option C: Breastfeeding-associated jaundice typically appears in a normal newborn between 2 to 4 days after birth. This timing is associated with the physiological adaptation of the newborn's liver and the increased bilirubin levels due to the breakdown of red blood cells and the effects of breast milk. Early breastfeeding can help mitigate this condition by promoting hydration and bowel movements, which assist in bilirubin elimination.

Option A: Jaundice appearing within 0 to 12 hours is indicative of pathological jaundice, often related to hemolytic disease or other underlying conditions, rather than breastfeeding-associated jaundice.

Option B: The onset of jaundice between 12 to 24 hours is also more characteristic of pathological causes, as breastfeeding-associated jaundice typically does not manifest until later.

Option D: Jaundice persisting until 4 to 5 days may suggest a prolonged physiological process or other complications, as breastfeeding-associated jaundice is expected to peak around 3 to 5 days but not to initiate at this time.

Takeaways: Understanding the timing of breastfeeding-associated jaundice is crucial for monitoring newborns, as it typically appears between 2 to 4 days, requiring appropriate breastfeeding support and monitoring to ensure healthy outcomes.

Option C: albuminuria, hypoproteinemia and edema defines the classic triad of nephrotic syndrome in children. These symptoms indicate significant protein loss through the kidneys, leading to low serum protein levels and resultant edema due to decreased oncotic pressure. This understanding is crucial for effective diagnosis and management in pediatric nephrology.

Option A: dyspnea, albuminuria and weight loss do not accurately represent nephrosis. While albuminuria is a symptom, dyspnea and weight loss are not characteristic features of nephrotic syndrome in children.

Option B: hematuria, hyperlipidemia and proteinuria includes proteinuria, but hematuria is not a typical symptom of nephrosis. Instead, hyperlipidemia is often present, but the combination does not define the classic presentation of nephrotic syndrome.

Option D: hypertension, hematuria and malnutrition do not align with the primary symptoms of nephrosis. Hypertension and hematuria are more associated with other renal conditions, while malnutrition is a consequence rather than a defining symptom of nephrotic syndrome.

Takeaways: Understanding the characteristic symptoms of nephrosis, specifically the triad of albuminuria, hypoproteinemia, and edema, is essential for accurate diagnosis and management in pediatric patients, especially when considering nephrotic syndrome treatment protocols.

Option A: Vomiting is a common clinical manifestation of a urinary tract infection (UTI) in infants, often resulting from systemic infection or dehydration. Infants may exhibit vomiting as a response to the infection, making it a key symptom to monitor in suspected cases.

Option B: Jaundice is primarily associated with liver dysfunction or hemolysis, not urinary tract infections. While jaundice can occur in infants, it does not correlate with UTIs and should be evaluated separately.

Option C: Failure to gain weight can be a sign of various underlying issues, but it is not a direct manifestation of a urinary tract infection. UTIs typically present with more acute symptoms rather than chronic weight gain issues.

Option D: Swelling of the face is not a typical manifestation of a urinary tract infection. This symptom may indicate other conditions such as allergic reactions or renal issues, which are not directly related to UTIs.

Takeaways: Recognizing that vomiting is a common clinical manifestation of urinary tract infections in infants is crucial for timely intervention, as it requires appropriate management and monitoring to prevent complications.

Option B: Family history would be least likely to provide valuable information in assessing for intussusception, as this condition is primarily related to acute abdominal symptoms and physical findings rather than hereditary factors.

Option A: Abdominal palpation is crucial in assessing for intussusception, as it can reveal abdominal tenderness, a palpable mass, or signs of obstruction.

Option C: Pain pattern is significant in this context, as intussusception often presents with intermittent severe abdominal pain, which can help in diagnosis.

Option D: Stool inspection can provide valuable information, particularly if there is the presence of

Option B: Amenorrhea is a well-documented adverse reaction associated with danazol (Danocrine), which is used to treat fibrocystic breast disease. Danazol acts as an androgen, suppressing ovarian function and leading to menstrual irregularities, including the cessation of menstruation. This side effect is significant and should be monitored in patients receiving this medication.

Option A: Nausea can occur with various medications, but it is not a specific or prominent adverse reaction linked to danazol. While some patients may experience gastrointestinal upset, it is not a defining characteristic of danazol therapy.

Option C: Confusion is not a typical adverse effect of danazol. Although hormonal therapies can sometimes affect mood or cognition, confusion is not a recognized or common reaction associated with this medication.

Option D: Hypotension is not a known side effect of danazol. The medication primarily affects hormonal levels rather than directly influencing blood pressure, making this option irrelevant in the context of danazol's adverse reactions.

Takeaways: Amenorrhea is a significant adverse reaction associated with danazol therapy for fibrocystic breast disease, highlighting the need for patient education regarding potential side effects prior to initiating treatment.